Zoster vaccine

Kate Dzintars, Pharm.D., BCPS, Edina Avdic, Pharm.D.
Zoster vaccine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

VACCINE TYPE

Shingrix® is a non-live subunit, adjuvanted vaccine (lyophilized recombinant).

Zostavax® is a live attenuated virus vaccine.

  • Zostavax® is no longer available for purchase as of June 30, 2020; all current doses in circulation expired on November 18, 2020.

-- To view the remaining sections of this topic, please or --

VACCINE TYPE

Shingrix® is a non-live subunit, adjuvanted vaccine (lyophilized recombinant).

Zostavax® is a live attenuated virus vaccine.

  • Zostavax® is no longer available for purchase as of June 30, 2020; all current doses in circulation expired on November 18, 2020.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 15, 2022